Washington University School of Medicine: New Drug Tested to Reduce Side Effect of 'Half-Matched' Stem Cell Transplants
December 06, 2024
December 06, 2024
ST. LOUIS, Missouri, Dec. 6 (TNSres) -- The Washington University School of Medicine issued the following news release:
* * *
Clinical trial indicates safety, fewer cases of life-threatening graft-versus-host disease than expected
* * *
Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side effect, according to an early-stage clinical trial conducted at Washington University School of Medicine . . .
* * *
Clinical trial indicates safety, fewer cases of life-threatening graft-versus-host disease than expected
* * *
Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side effect, according to an early-stage clinical trial conducted at Washington University School of Medicine . . .